294 results on '"Milinkovic, Ana"'
Search Results
2. Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV
3. COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2
4. Cardiometabolic health in people with HIV: expert consensus review
5. Sleep disturbances and their correlation with cardiovascular risk, obesity, and mood disorders in people with HIV
6. Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial
7. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial
8. Depression is associated with poor self-reported adherence to antiretroviral therapy among people living with HIV attending an HIV clinic in the UK: results from a cross-sectional study
9. HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment
10. Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL)
11. Risky Alcohol Consumption and Associated Health Behaviour Among HIV-Positive and HIV-Negative Patients in a UK Sexual Health and HIV Clinic: A Cross-Sectional Questionnaire Study
12. Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL).
13. Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV‐negative controls: A cross‐sectional study nested within the POPPY cohort.
14. Two vicious circles associated with the aging of the immune system in the development of severe forms of COVID-19
15. Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV
16. Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial
17. Results of a Multi-Disciplinary Approach Involving Geriatricians of a Clinic for Older People Living with HIV
18. Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL)
19. Use of Coronary Artery Calcium Scoring to Improve Cardiovascular Risk Stratification and Guide Decisions to Start Statin Therapy in People Living With HIV
20. Incidental findings in elderly people living with HIV undergoing computed tomography coronary artery calcium scoring
21. No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV
22. Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back
23. Lipid changes due to tenofovir alafenamide are reversible by switching back to tenofovir disoproxil fumarate
24. Investigating if switching HIV patients from stable combined antiretroviral therapy to Delstrigo has fewer unwanted side effects e.g. weight gain, while being just as effective at maintaining an undetectable HIV viral load
25. Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens
26. Multi-tablet, Single-Tablet, or Long-Acting Antiretroviral Treatment for HIV: A Cross-sectional Study of Patient Preferences in the United States and Spain
27. Correlation between different equations to calculate free testosterone for improved detection of hypogonadism in people living with HIV
28. Delivering specialised care to people ageing with HIV in the UK: experience and evolution of services from 2009 to 2019
29. Evaluation of a Clinic Dedicated to People Aging with HIV at Chelsea and Westminster Hospital: Results of a 10-Year Experience
30. Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial
31. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial
32. COVAC1 Phase 2a Expanded Safety and Immunogenicity Study of a Self-Amplifying RNA Vaccine Against SARS-CoV-2
33. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study
34. Predictive Value of HIV-Related Versus Traditional Risk Factors for Coronary Atherosclerosis in People Aging with HIV
35. FRAX assessment in people ageing with HIV
36. A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cobicistat on renal function in HIV-1 antiretroviral naïve patients
37. The benefits of tenofovir discontinuation with or without bisphosphonate therapy in osteoporotic people living with HIV
38. HCV reinfection after HCV therapy among HIV/HCV���coinfected individuals in Europe
39. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
40. HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe.
41. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.
42. Factors associated with overweight/obesity in a cohort of people living with HIV over 50 years of age
43. MRI signal changes of the bone marrow in HIV-infected patients with lipodystrophy: correlation with clinical parameters
44. Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against COVID-19: COVAC1, a Phase I, Dose-Ranging Trial
45. Gynecomastia among HIV-infected patients is associated with hypogonadism: a case-control study
46. Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals
47. Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1
48. Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir
49. Short Communication: Predictive Value of HIV-Related Versus Traditional Risk Factors for Coronary Atherosclerosis in People Aging with HIV.
50. FRAX assessment in people ageing with HIV.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.